| For: | Kong YH, Xu ML, Zhang JJ, Chen GQ, Hong ZH, Zhang H, Dai XX, Ma YF, Zhao XR, Zhang CY, Chen RZ, Xing PF, Zhang LY. PRaG 3.0 therapy for human epidermal growth factor receptor 2-positive metastatic pancreatic ductal adenocarcinoma: A case report. World J Gastroenterol 2024; 30(9): 1237-1249 [PMID: 38577174 DOI: 10.3748/wjg.v30.i9.1237] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i9/1237.htm |
| Number | Citing Articles |
| 1 |
Jiabao Yang, Xiangrong Zhao, Pengfei Xing, Yuehong Kong, Meiling Xu, Liyuan Zhang. Efficacy of PRaG therapy in microsatellite-stable metastatic colorectal cancer: a comparative analysis of PD-1/PD-L1 inhibitor-based combination therapies. Cancer Immunology, Immunotherapy 2025; 74(11) doi: 10.1007/s00262-025-04185-y
|
| 2 |
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments from January to June 2024. World Journal of Gastroenterology 2024; 30(34): 3875-3882 doi: 10.3748/wjg.v30.i34.3875
|
| 3 |
|
